Alpha Centric Advisors LLC Johnson & Johnson Transaction History

Alpha Centric Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$155.75 - $174.48 $7,008 - $7,851	-45 Reduced 3.06%	1,426 $222,000
Q2 2023 Aug 08, 2023	SELL	$154.35 - $166.11 $16,361 - $17,607	-106 Reduced 6.72%	1,471 $243,000
Q1 2023 May 12, 2023	SELL	$151.05 - $180.26 $2,869 - $3,424	-19 Reduced 1.19%	1,577 $244,000
Q4 2022 Feb 07, 2023	BUY	$160.2 - $179.79 $255,679 - $286,944	1,596 New	1,596 $282,000

4,161

1.69B

12.5M

10.3M

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $431B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

Get notified when there are updates to the investment portfolio of Alpha Centric Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Alpha Centric Advisors LLC with notifications on news.